Valuation : TransMedics Group, Inc.

Market Cap 3.12B 2.68B 2.53B 2.31B 4.32B 295B 4.33B 29.85B 11.58B 151B 11.72B 11.46B 487B P/E 2026 *
64.6x
P/E 2027 * 40.9x
Enterprise Value 3.08B 2.65B 2.49B 2.28B 4.26B 291B 4.27B 29.46B 11.43B 149B 11.56B 11.31B 481B EV / Sales 2026 *
4.15x
EV / Sales 2027 * 3.4x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day+3.45%
1 week+1.75%
Current month+6.02%
1 month+11.43%
3 months+26.08%
6 months-39.06%
Current year-26.03%
1 week 81.34
Extreme 81.3401
90.11
1 month 75
Extreme 75
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 A Don

Chairman

-18,000 0.0528%
7/10/26 A Free

Chief Financial Officer

43,399 0.1273%
7/10/26 A Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
+3.45%+1.75%-13.52%+30.18% 3.12B
-0.75%-1.35%+25.39%+10.15% 227B
-1.60%-3.89%+4.34%-21.81% 146B
-0.85%-1.58%-19.32%+18.13% 130B
+1.81%+2.05%-55.45%-10.85% 69.27B
+0.13%-0.34%+11.04%+17.70% 51.82B
+0.49%-1.32%-17.27%-14.42% 50.45B
+0.59%-1.94%+17.42%+23.75% 42.53B
-1.01%-1.28%+36.60%+45.68% 40.22B
-1.55%+1.22%+123.40%+29.54% 32.95B
Average +0.13%-1.23%+11.26%+12.80% 79.28B
Weighted average by Cap. -0.43%-1.54%+7.55%+6.08%

Financials

2026 *2027 *
Net sales 742M 638M 600M 549M 1.03B 70.03B 1.03B 7.1B 2.75B 35.93B 2.79B 2.72B 116B 875M 753M 708M 647M 1.21B 82.59B 1.21B 8.37B 3.25B 42.37B 3.28B 3.21B 137B
Net income 51.99M 44.74M 42.09M 38.45M 71.93M 4.91B 72.12M 497M 193M 2.52B 195M 191M 8.11B 89.08M 76.65M 72.12M 65.88M 123M 8.41B 124M 852M 331M 4.32B 335M 327M 13.9B
Net Debt -40.26M -34.64M -32.59M -29.77M -55.7M -3.8B -55.85M -385M -149M -1.95B -151M -148M -6.28B -146M -125M -118M -108M -202M -13.75B -202M -1.39B -541M -7.06B -547M -535M -22.73B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
04/09/26 $89.98 +3.45% 542,804
03/09/26 $86.98 +3.19% 574,877
02/09/26 $84.29 +2.49% 589,835
01/09/26 $82.24 -3.10% 883,990
31/08/26 $84.87 -4.03% 1,185,420
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
89.98USD
Average target price
97.30USD
Spread / Average Target
+8.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock